Augmenix – Catalyst Health Ventures

Skip to content Skip to footer

Catalyst Health Ventures

Home
About
Portfolio
Meet Our Team
News
Connect

1 800 458 56 97

Investor Portal

Catalyst Health Ventures

Investor Portal

Home
About
Portfolio
Meet Our Team
News
Connect

Get in Touch

Our Address

129 South Street, 4th Floor,
Boston, MA 02111

Investor Portal

AugmenixOctober 17, 2018

Boston Scientific Closes $600m Augmenix Buyout

Catalyst Health Ventures (CHV) is a venture capital firm investing in transformative medical technologies addressing global unmet needs.

Office

129 South Street, 4th Floor,
Boston, MA 02111

Links

Home
About
Portfolio
Meet Our Team
News
Connect

Get In Touch

LinkedIn

© 2025 Catalyst Health Ventures. All Rights Reserved | Site By ConvyLab